Answers are grounded in this paper and cite their sources.
Uric acid (UA) serves as a key biomarker for gout, cardiovascular disease, and kidney dysfunction, yet conventional detection methods relying on H 2 O 2 generation suffer from signal instability and interference from reductive species. Here, we report a uricase-like platinum-nitrogen-carbon nanozyme (Pt-N-C-NH 3 ) that redirects UA oxidation from a two-electron pathway toward a four-electron pathway. By decreasing graphitic nitrogen content, the local electronic microenvironment of platinum sites is modulated, which is associated with a lower calculated free-energy change for the rate-determining absorbed oxygen to absorbed hydroxyl transformation from 1.25 to 0.62 electron volts and thereby promoting oxygen reduction to water. Integrated into a microneedle sensing platform, UA is converted to allantoin for chemiluminescent readout. The sensor exhibits a wide linear range of 50.00 to 1000.00 μM and a detection limit of 15.86 μM, while maintaining 97.57% signal stability against reductive interferents. This work demonstrates that atomic-level coordination engineering enables programmable control over reaction pathways in artificial enzyme systems, thereby facilitating robust biosensing in complex biological environments.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: